Fending off oral thrush
Oral infections may play a role in the development of cardiovascular and respiratory diseases. Medical student Maria Angela Grima takes a look at the causes and symptoms of oral candidiasis and identifies who is most at risk. Maintaining oral health is ...
Times of Malta - Fri, 19 Sep 2014 03:30



Quadruple Dosing of Doripenem Safe in Patients With CF
... and the researchers suggest that this could have contributed to anemia and gastrointestinal complaints, including diarrhea (25.6%), nausea, vomiting or antiemetic use (20.9%), Clostridium difficile infection (7%), and oral candidiasis/oral nystatin ...
Medscape - Sun, 07 Sep 2014 09:30

[Dash of SAS] A lifeline running out
The pneumonia was compounded by oral candidiasis, a condition where the lining of the mouth is infected with fungus. It became painful for him to swallow food or drink water, and his weight dropped to about 70 pounds – half of his original weight.
Rappler - Tue, 16 Sep 2014 19:53

FDA grants 'orphan' drug status to Viamet fungus fighter
The Company's lead product candidate, VT-1161, is an oral treatment for recurrent vulvovaginal candidiasis, an infection of the mucus membranes in women's genitals for which there are no approved therapies in the United States. VT-1161 is also being ...
WRAL Tech Wire - Fri, 12 Sep 2014 07:08

Data for Viamet's VT-1161 Presented at ICAAC 2014
RESEARCH TRIANGLE PARK, N.C. — Viamet Pharmaceuticals today reported that positive preclinical studies for VT-1161, the Company's lead novel, oral antifungal compound were presented at the 54th Interscience Conference on Antimicrobial Agents and ...
Rock Hill Herald (press release) - Wed, 10 Sep 2014 07:03

Extensive data presented on Basilea's anti-infectives isavuconazole ...
Isavuconazole for the treatment of candidiasis is currently being explored in the ongoing phase 3 study ACTIVE, which evaluates the safety and efficacy of intravenously (i.v.) and orally administered isavuconazole versus i.v. caspofungin followed by ...
NASDAQ - Thu, 04 Sep 2014 22:15

Basilea's partner Astellas receives notification from US FDA of acceptance of ...
Isavuconazole (drug substance:isavuconazonium sulfate) is an investigational once-daily intravenous and oral broad-spectrum antifungal for the potential treatment of life-threatening invasive fungal infections which predominantly occur in ...
MarketWatch - Sat, 06 Sep 2014 05:22

New method shows how bacteria become dangerous pathogens
Two new papers published this month reveal how bacteria can become dangerous pathogens through completely different routes. One paper shows how a bacterium responsible for serious infection in newborns gained an advantage because it acquired ...
Medical News Today - Tue, 19 Aug 2014 03:09


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014